Adaptyv Biosystems
About this raise
Adaptyv Biosystems, with a valuation of $12 million, is raising funds on Wefunder. The company uses synthetic biology and nanofluidics for protein engineering. The business and its technology interface with standard antibody discovery pipelines and massively increase the number of antibodies that can be screened. Adaptyv Biosystems is working on building the best platform to engineer proteins based on high-throughput nanofluidics and train machine-learning models to predict new protein designs. Julian Englert, Moustafa Homani, Amir Shahein, and Daniel Nakhaee Zadeh Gutierrez founded Adaptyv Biosystems in July 2021. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $107,000. The campaign proceeds will be used for R&D expenses.
Investment Overview
Invested : $52,773
Deal Terms
Total Commitments
- Platform
- Wefunder
- Start Date
- 11/23/2021
- Close Date
- 03/21/2022
$50,000
$107,000
$100
SAFE
Early Stage
RegCF
$12,000,000
0%
Company & Team
Company
- Year Founded
- 2021
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2C
- Margin
- Medium
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 03/21/2022 | Wefunder | $12,000,000 | $52,773 | SAFE | Funded | RegCF |